Vitamin D and its analogue in treating Periodontal diseases
![vitamin d vitamin d](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhZxR8DFVLrgBfXKHpFLeW0BxWgq_EsFJC03EWDTcgCFze-1wp58bqB79WH5EGOYt-lGU5XX1uiM_PFyp5WJlVDowx8sWbCmkQVgI74Af7Mfpm3n9pDwe6TdtGz_qUX3Q5MvadF3nvbFSr3/s320/art-5.png)
A variety of pathways for the “perioprotective” function of
vitamin D have been elucidated. An important property of vitamin D is its
ability to induce the antimicrobial peptide, human cathelicidin LL-37, and
increase expression of the genes coding for microbial pattern recognition receptors.
LL-37 has the ability to eliminate microbes through diverse mechanisms, which
might play a key role in restricting the development of resistant bacterial
strains. In addition to its anti-microbial activities, LL-37 has been
demonstrated to elicit a plethora of pleiotropic effects. LL-37 has the ability
to strengthen the innate barrier, reduce pro-inflammatory cytokines, and
stimulate proliferation and migration of epithelial cells. LL-37 has also been
reported to inhibit in vitro osteoclastogenesis and down-regulate expression of
osteoclast genes. Monocytes, neutrophils and subsets of T lymphocytes have
chemotactic receptors that respond to LL-37. LL-37 induces proliferation and
migration of human epithelial cells and enhances activities which promote wound
healing. The topical use of vitamin D in psoriasis (chronic inflammatory
skin disease) has been shown to increase LL-37 levels and suppress the
production of pro-inflammatory cytokines IL-12/23, IL-1α, IL-1β, and TNF-α. Read more.........
Comments
Post a Comment